Advertisement

Intracranial Hemorrhage in Association with Thrombolysis: Multiple Causes and Risk Factors (No Simple Answer)

  • M. S. Pessin
  • G. J. del Zoppo
Conference paper

Abstract

The simple view to account for intracranial hemorrhage (ICH) in acute stroke patients treated with thrombolytic agents has been reperfusion bleeding into an area of infarcted tissue from an occluded, then recanalized, artery weakened by an ischemic insult. However, the emerging data from the acute myocardial infarction (MI) and the acute stroke studies suggest that the origin of ICH may be more complex. The occurrence of symptomatic, even debilitating ICH in the setting of thrombolytic therapy for acute MI and for acute stroke is the major safety concern.

Keywords

Acute Stroke Acute Ischemic Stroke Intracranial Bleeding Thrombolytic Therapy Tissue Plasminogen Activator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kase CS, O’Neal AM, Fisher M, Girgis GN, Ordia JI (1990) Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med 112: 17–21PubMedGoogle Scholar
  2. 2.
    Sloan MA, Price TR, Petito CK, Randall AMY, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, Babb J, Herman M, Roberts WC, Sopko G, Bovill E, Forman S, Knatterud GL, for the TIMI Investigators (1995) Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the TIMI II pilot and randomized trial combined experience. Neurology 45: 649–658Google Scholar
  3. 3.
    Sloan MA, Price TR (1991) Intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction. Semin Neurol 11: 385–399PubMedCrossRefGoogle Scholar
  4. 4.
    Gore JM, Sloan M, Price TR, Randall AMY, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML, and the TIMI Investigators (1991) Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study. Thrombolysis in myocardial infarction, phase II, pilot and clinical trial. Circulation 83: 448–459Google Scholar
  5. 5.
    Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, de Jaegere P, van Domburg R, Boersma E, Franzosi MG, Califf R, Schroder R, Braunwald E (1993) Individual risk assessment for intracranial hemorrhage during thrombolytic therapy. Lancet 342: 1523–1528PubMedCrossRefGoogle Scholar
  6. 6.
    The GUSTO investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673–682CrossRefGoogle Scholar
  7. 7.
    Proner J, Rosenblum BR, Rothman A (1990) Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator. Arch Neurol 47: 105–106PubMedCrossRefGoogle Scholar
  8. 8.
    Ramsay DA, Penswick JL, Robertson DM (1990) Fatal streptokinase-induced intracerebral hemorrhage related to cerebral amyloid angiopathy. Can J Neurol Sci 17: 336–341PubMedGoogle Scholar
  9. 9.
    Pendlebury WW, Tole ED, Tracy RP, Dill BA (1991) Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Neurol 29: 210–213PubMedCrossRefGoogle Scholar
  10. 10.
    Leblanc R, Haddad G, Robitaille Y (1992) Cerebral hemorrhage from amyloid angiopathy after coronary thrombolysis. Neurosurgery 31: 586–590PubMedCrossRefGoogle Scholar
  11. 11.
    Wijdicks EFM, Jack CR (1993) Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 24: 554–557PubMedCrossRefGoogle Scholar
  12. 12.
    Uglietta J, O’Connor CM, Boyko OB, et al (1991) CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Radiology 181: 555–559PubMedGoogle Scholar
  13. 13.
    Bogousslaysky J, Regli F, Uské A, Maeder P (1991) Early spontaneous hematoma in cerebral infarct: is primary cerebral hemorrhage overdiagnosed? Neurology 41: 837–840Google Scholar
  14. 14.
    Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rt-PA Acute Stroke Study Group (1993) Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR 14: 3–13Google Scholar
  15. 15.
    Sackett DL (1986) Rules of evidence and clinical recommendations on the use of anti-thrombotic agents. Chest 89 (suppl): 2S - 3SGoogle Scholar
  16. 16.
    del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A. Alberts MJ, Zivin JA, Wechsler L, Busse O. Greenlee R, Brass L. Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86PubMedCrossRefGoogle Scholar
  17. 17.
    Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976–982PubMedGoogle Scholar
  18. 18.
    on Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23: 646–652CrossRefGoogle Scholar
  19. 19.
    Yamaguchi T. Hayakawa T, Kikuchi H, Abe T (1991) Thrombolytic therapy in embolic and thrombotic cerebral infarction: a cooperative study. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer. Berlin, pp 168–174CrossRefGoogle Scholar
  20. 20.
    Yamaguchi T, Hayakawa T, Kikuchi M, for the Japanese Thrombolysis Study Group (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double-blind trial. In: del Zoppo GJ, Mori E. Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin. pp 59–65Google Scholar
  21. 21.
    Brott TG, Haley EC, Levy DE, Barsan W, Broderick J. Sheppard GL. Spilker J. Kongable GL, Massey S, Reed R, Marler JR (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23: 632–640PubMedCrossRefGoogle Scholar
  22. 22.
    Haley EC, Levy DE, Brott TG. Sheppard GL, Wong MCW. Kongable GL. Torner JC. Marier JR (1992) Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 23: 641–645PubMedCrossRefGoogle Scholar
  23. 23.
    Haley EC, Brott TG, Sheppard GL, Barsan W, Broderick J, Mader JR, Konable GL, Spilker J, Massey S, Hansen CA, Toner JC, for the TPA Bridging Study Group (1993) Pilot randomized trial of tissue plasminogen activator in acute stroke. Stroke 24: 1000–1004CrossRefGoogle Scholar
  24. 24.
    Sherman DG, and the Ancrod Investigators (1993) Ancrod for the treatment of acute ischemic stroke. Ann Neurol 34: 251Google Scholar
  25. 25.
    del Zoppo GJ, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, Harker LA, Zeumer H (1988) Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke 19: 307–313Google Scholar
  26. 26.
    Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802–812PubMedCrossRefGoogle Scholar
  27. 27.
    Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D (1989) Local intraarterial fibrinolysis in the carotid territory. AJNR 10: 753–765PubMedGoogle Scholar
  28. 28.
    Matsumoto K, Satoh K (1991) Topical intraarterial urokinase infusion for acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer, Berlin, pp 207–212CrossRefGoogle Scholar
  29. 29.
    Zeumer H, Freitag H-J, Zanella F. Thie A, Arning C (1993) Local intraarterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 35: 159–162PubMedCrossRefGoogle Scholar
  30. 30.
    Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19: 1216–1222PubMedCrossRefGoogle Scholar
  31. 31.
    Möbius E, Berg-Dammer E, Kühne D, Nahser HC (1991) Local thrombolytic therapy in acute basilar artery occlusion: experience with 18 patients. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer, Berlin, pp 213–215CrossRefGoogle Scholar
  32. 32.
    Levy DE, Brott TG, Haley EC, Marler JR, Sheppard GL, Barsan W, Broderick JP (1994) Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25: 291–297PubMedCrossRefGoogle Scholar
  33. 33.
    Kaste M, Hacke W, Fieschi C, for the ECASS Study Group (1994) ECASS: Safety data from the pilot study and the first 160 randomized patients. Stroke 25: 256Google Scholar
  34. 34.
    Lee JH, Seo DC. Kim JS, Lee MC (1994) Therapeutic efficacy of urokinase and heparin in acute ischemic stroke. Stroke 25: 268Google Scholar
  35. 35.
    Fisher CM, Adams RD (1951) Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 10: 92–94PubMedGoogle Scholar
  36. 36.
    Ogata J, Yutani C, Imakita M, Ishibashi-Ueda H. Saku Y, Minematsu K, Sawada T, Yamaguchi T (1989) Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke 20: 876–883PubMedCrossRefGoogle Scholar
  37. 37.
    Pessin MS, Wolpert SM, for the rt-PA Acute Stroke Study Group (1993) The significance of various factors associated with hemorrhagic transformation in patients treated with recombinant tissue plasminogen activator for acute stroke. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin, pp 145–152Google Scholar

Copyright information

© Springer-Verlag Tokyo 1995

Authors and Affiliations

  • M. S. Pessin
    • 1
  • G. J. del Zoppo
    • 2
  1. 1.New England Medical CenterBostonUSA
  2. 2.Scripps Clinic & Research FoundationLa JollaUSA

Personalised recommendations